German Hospitality Stock News

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights BASF's estimated fair value is €63.91 based on 2 Stage Free Cash Flow to Equity BASF's €43.81 share price...

Despite posting some strong earnings, the market for Deufol SE's ( HMSE:DE10 ) stock hasn't moved much. We did some...

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 18x, you may consider...

Turbon AG ( FRA:TUR ) shares have had a really impressive month, gaining 26% after a shaky period beforehand. Not all...

Hannover Rück (ETR:HNR1) has had a rough three months with its share price down 13%. However, stock prices are usually...

Key Insights AIXTRON's estimated fair value is €18.56 based on 2 Stage Free Cash Flow to Equity Current share price of...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

Most readers would already be aware that Regenbogen's (FRA:RGB) stock increased significantly by 33% over the past...

Softing AG ( ETR:SYT ) shareholders would be excited to see that the share price has had a great month, posting a 25...

Despite posting healthy earnings, Adler Group S.A.'s ( ETR:ADJ ) stock has been quite weak. Our analysis suggests that...

Geratherm Medical AG's ( ETR:GME ) robust recent earnings didn't do much to move the stock. However the statutory...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Nordex SE ( ETR:NDX1 ), might not be a large cap stock, but it saw a significant share price rise of 25% in the past...

As European markets face challenges from political instability and renewed tariff uncertainties, the pan-European STOXX Europe 600 Index recently ended lower, reflecting broader concerns about economic resilience. In this environment, growth companies with high insider ownership can offer a unique appeal, as insider commitment often signals confidence in a company's long-term potential amidst market fluctuations.

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Key Insights Given the large stake in the stock by institutions, Symrise's stock price might be vulnerable to their...

Key Insights PUMA's estimated fair value is €22.27 based on 2 Stage Free Cash Flow to Equity PUMA's €19.94 share price...

The Redcare Pharmacy NV ( ETR:RDC ) share price has fared very poorly over the last month, falling by a substantial...

There wouldn't be many who think sdm SE's ( FRA:75S ) price-to-sales (or "P/S") ratio of 0.2x is worth a mention when...

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...

Fielmann Group AG recently reported its second quarter and half-year 2025 earnings, posting higher sales, revenue, and net income compared to the same periods last year. The company's basic earnings per share from continuing operations also increased, reflecting ongoing operational improvements throughout the first half of the year. We'll explore how Fielmann's continued growth in both revenue and net income supports its broader investment narrative. AI is about to change healthcare. These...

ZEISS Medical Technology announced in August 2025 that it had received CE mark approval for CIRRUS PathFinder, an artificial intelligence-powered clinical support tool designed to enhance OCT interpretation and workflow efficiency for clinicians. This development highlights ZEISS's commitment to integrating deep learning algorithms into its medical imaging products, aiming to advance both practice efficiency and quality of patient care. We'll explore how the CE mark approval for the...